Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?

Autor: Sher Storey, Arielle Davis, Sharon K. Sahi, Shelia B. Dunaway, Abby Crooks, Christina M. Marra, Lauren C. Tantalo, Kevin Robertson, Clare L. Maxwell, Haley Mendoza, Claire E. Stevens
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Bacterial Diseases
RNA viruses
Physiology
Epidemiology
Social Sciences
Pathology and Laboratory Medicine
Spinal Puncture
Nervous System
Treponematoses
White Blood Cells
Medical Conditions
0302 clinical medicine
Cerebrospinal fluid
Immunodeficiency Viruses
CSF pleocytosis
Neurosyphilis
Risk Factors
Animal Cells
Medicine and Health Sciences
Psychology
030212 general & internal medicine
Cognitive decline
Cognitive impairment
Treponema Pallidum
Cerebrospinal Fluid
Cognitive Impairment
Multidisciplinary
medicine.diagnostic_test
Cognitive Neurology
T Cells
Cognition
Hydrogen-Ion Concentration
Body Fluids
Bacterial Pathogens
Infectious Diseases
Neurology
Medical Microbiology
Viral Pathogens
Viruses
Medicine
Anatomy
Pathogens
Cellular Types
Research Article
Neglected Tropical Diseases
medicine.medical_specialty
Cognitive Neuroscience
Urology
Immune Cells
Science
Immunology
Sexually Transmitted Diseases
Microbiology
03 medical and health sciences
Neuropsychology
Internal medicine
Retroviruses
medicine
Humans
Cognitive Dysfunction
Syphilis
Microbial Pathogens
Neuropsychological Testing
Blood Cells
Genitourinary Infections
Lumbar puncture
business.industry
Lentivirus
Organisms
Biology and Life Sciences
HIV
Cell Biology
Tropical Diseases
medicine.disease
Medical Risk Factors
Cognitive Science
business
030217 neurology & neurosurgery
Neuroscience
Zdroj: PLoS ONE, Vol 16, Iss 7, p e0254518 (2021)
PLoS ONE
ISSN: 1932-6203
Popis: Background Individuals with previous syphilis may experience cognitive impairment. The goal of this study was to determine if those at high risk for laboratory-defined neurosyphilis are cognitively impaired, and whether treatment based on cerebrospinal fluid (CSF) findings results in better outcomes. Methods Participants had a new syphilis diagnosis, serum RPR titer ≥ 1:32 or peripheral blood CD4+ T cells ≤ 350/ul (in persons living with HIV) and did not endorse neurological symptoms. They underwent computerized cognitive assessment with the CogState. Thirty-two were randomized to either undergo lumbar puncture (LP) or to not undergo LP and 14 underwent LP; 64 were not randomized and 48 opted to undergo LP. Results Demographics, cognitive complaints and cognitive impairment did not differ between randomized and nonrandomized participants. Two-thirds were cognitively impaired, and impairment was not more common in those with cognitive complaints. The adjusted odds of increased severity of impairment were 3.8 times greater in those with CSF pleocytosis compared to those without. Time to cognitive normalization, improvement or decline did not differ between those who did not undergo LP and those who underwent LP and whose treatment was based on CSF analysis. Taking into account pre-treatment cognitive impairment, the risk of cognitive decline was lower in those with CSF pleocytosis treated for neurosyphilis compared to those without CSF pleocytosis not treated for neurosyphilis, (HR 0.24 (95% CI 0.07–0.88], p = 0.03). Conclusion In individuals at high risk for laboratory-defined neurosyphilis, cognitive complaints are not a good indicator of cognitive impairment. Severity of cognitive impairment was greater in those with CSF pleocytosis. Identification and treatment of those with neurosyphilis may mitigate subsequent cognitive decline.
Databáze: OpenAIRE